Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Cardiac risk in the treatment of breast cancer: assessment and management
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology.
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm, Centre for Clinical Research, County of Västmanland. Vastmanlands Cty Hosp, Ctr Clin Res, Vasteras, Sweden..
2015 (English)In: Breast Cancer: Targets and Therapy, ISSN 1179-1314, E-ISSN 1179-1314, Vol. 7, 21-35 p.Article, review/survey (Refereed) Published
Resource type
Text
Abstract [en]

As the number of long-term breast cancer survivors has increased, the side effects of adjuvant cancer therapy, such as cardiac toxicity, remain clinically important. Although the cardiac toxicity due to anthracyclines, radiotherapy, or trastuzumab is well-documented, several issues need to be clarified and are the subjects of extensive ongoing clinical research. This review summarizes the incidence of cardiac toxicity due to breast cancer adjuvant therapy and highlights the current trends in early detection and management of cardiac toxicities.

Place, publisher, year, edition, pages
2015. Vol. 7, 21-35 p.
Keyword [en]
adjuvant, anthracyclines, cardiac toxicity, radiotherapy, trastuzumab
National Category
Cancer and Oncology Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:uu:diva-276111DOI: 10.2147/BCTT.S47227ISI: 000366124300001PubMedID: 25653554OAI: oai:DiVA.org:uu-276111DiVA: diva2:901902
Available from: 2016-02-09 Created: 2016-02-09 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

fulltext(309 kB)52 downloads
File information
File name FULLTEXT01.pdfFile size 309 kBChecksum SHA-512
607c32ee0dcba218476a06b90a7610dd5f69babb2f70f9c7b6b53df855c4aa04694253923d286b7fcc4fd9c7c1acd647221e988c6c0bcf265487cf49b50c80ca
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Valachis, Antonis
By organisation
Experimental and Clinical OncologyCentre for Clinical Research, County of Västmanland
In the same journal
Breast Cancer: Targets and Therapy
Cancer and OncologyCardiac and Cardiovascular Systems

Search outside of DiVA

GoogleGoogle Scholar
Total: 52 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 215 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf